Compare NDAQ & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NDAQ | CAH |
|---|---|---|
| Founded | 1971 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3B | 49.1B |
| IPO Year | 2002 | N/A |
| Metric | NDAQ | CAH |
|---|---|---|
| Price | $82.48 | $221.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | $104.00 | ★ $225.80 |
| AVG Volume (30 Days) | ★ 5.1M | 1.8M |
| Earning Date | 01-29-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.25% | 0.90% |
| EPS Growth | ★ 60.10 | 29.45 |
| EPS | 3.09 | ★ 6.94 |
| Revenue | $8,218,000,000.00 | ★ $244,673,000,000.00 |
| Revenue This Year | N/A | $16.99 |
| Revenue Next Year | $8.13 | $9.27 |
| P/E Ratio | ★ $27.93 | $32.51 |
| Revenue Growth | ★ 11.05 | 10.08 |
| 52 Week Low | $64.84 | $120.72 |
| 52 Week High | $101.79 | $230.81 |
| Indicator | NDAQ | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 25.19 | 58.23 |
| Support Level | $84.12 | $205.87 |
| Resistance Level | $89.47 | $230.20 |
| Average True Range (ATR) | 3.17 | 5.95 |
| MACD | -1.79 | 1.01 |
| Stochastic Oscillator | 2.17 | 62.80 |
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.